SINCLAIR MICHAEL sold 41.5% of their position (13.62K shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $149.2K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/15/2022ACC: 0001385508-22-000092
Director10% Owner
Since Sep 2019
-13.62K
Net shares
Net seller
$149.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
13.62K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−5.49K
Price / share
$11.09
Trade value
$60.90K
% of position
16.7%
6/13/2022
32.84K→27.34K
Common Stock
Direct
Shares
−7.22K
Price / share
$10.90
Trade value
$78.75K
% of position
26.4%
6/14/2022
27.34K→20.12K
Common Stock
Direct
Shares
−900.00
Price / share
$10.60
Trade value
$9.54K
% of position
4.5%
6/15/2022
20.12K→19.22K
Total
Net shares
−13.62K
Net value
-$149.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/13/2022 | S · Sale | −5.49K | $11.09 | $60.90K | 16.7% | 32.84K | 27.34K |
| Common Stock Direct | 6/14/2022 | S · Sale | −7.22K | $10.90 | $78.75K | 26.4% | 27.34K | 20.12K |
| Common Stock Direct | 6/15/2022 | S · Sale | −900.00 | $10.60 | $9.54K | 4.5% | 20.12K | 19.22K |
| Total | −13.62K | -$149.19K | ||||||
Derivative Transactions0
No derivative transactions reported